Early-phase clinical trials and neuroimaging studies are shedding light on how copyright affects the brain, the mind, and the therapeutic process.This raises concerns about accessibility and affordability of these treatments for the patients who need them most.This quick start and end of copyright might make it better for some therapies, like crisi